TORONTO, July 18, 2014 /CNW/ - Marc Wayne, President and CEO of Bedrocan Canada, Inc. will be featured in a one-on-one interview with markets commentator Andrew McCreath today at 4:30 pm ET. Mr. McCreath is the host of Weekly on the Business News Network (BNN). The feature will also be archived for viewing on the BNN.ca web page for Weekly with Andrew McCreath.
The interview will cover the evolution of the use of medicinal cannabis in Canada, and highlight Bedrocan's unique strengths in the market, as the company prepares for its upcoming public listing on the TSX Venture Exchange via a Qualifying Transaction with POCML 2 Inc. (TSX-V:PCC.P).
Mr. Wayne will discuss Bedrocan's experience of more than 10 years as a producer of government-approved medicinal cannabis in Europe and Canada, and the only source of legally-exported cannabis in the world. He will also cover Bedrocan's focus on cannabis research and product innovation, and the need to provide patients and health care professionals with the highest-quality standardized pharmaceutical-grade cannabis, for the symptomatic management of a variety of serious health conditions.
Bedrocan Canada is affiliated and partnered with "Bedrocan BV" of the Netherlands. "Bedrocan Canada Inc", is a Canadian company with extensive knowledge and experience in the use of cannabis and cannabinoids in clinical practice.
For more than 10 years, Bedrocan has worked with universities, industry, government, and NGO partners in Europe and around the world to conduct the genetic, botanical, chemical, and social research necessary to help cannabis meet the regulatory demands of modern medicine. Bedrocan has been licensed since December, 2013, to supply medicinal cannabis to meet the needs of patients registered with Health Canada to receive cannabis as medicine.
Image with caption: "Bedrocan Canada Inc. (CNW Group/Bedrocan Canada Inc.)". Image available at: http://photos.newswire.ca/images/download/20140718_C8219_PHOTO_EN_42191.jpg
SOURCE: Bedrocan Canada Inc.
For further information: